Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-15-012320
Filing Date
2015-08-19
Accepted
2015-08-19 13:33:24
Documents
1
Period of Report
2015-08-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3478
  Complete submission text file 0001179110-15-012320.txt   4849
Mailing Address 675 WEST KENDALL STREET CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET CAMBRIDGE MA 02142 617 491-9700
MOMENTA PHARMACEUTICALS INC (Issuer) CIK: 0001235010 (see all company filings)

EIN.: 043561634 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O MOMENTA PHARMACEUTICALS, INC 675 WEST KENDALL ST CAMBRIDGE MA 02142
Business Address
Leicher Bruce (Reporting) CIK: 0001345695 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50797 | Film No.: 151063534